These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20890423)
21. Gfer inhibits Jab1-mediated degradation of p27kip1 to restrict proliferation of hematopoietic stem cells. Teng EC; Todd LR; Ribar TJ; Lento W; Dimascio L; Means AR; Sankar U Mol Biol Cell; 2011 Apr; 22(8):1312-20. PubMed ID: 21346186 [TBL] [Abstract][Full Text] [Related]
22. Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells. Fei M; Hang Q; Hou S; He S; Ruan C Mol Cell Biochem; 2014 Jan; 386(1-2):177-87. PubMed ID: 24170542 [TBL] [Abstract][Full Text] [Related]
23. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions. Ivan D; Diwan AH; Esteva FJ; Prieto VG Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004 [TBL] [Abstract][Full Text] [Related]
24. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors. Lee WS; Park ES; Kim DH; Kim TH; Lee HH; Chung SH Eur J Gynaecol Oncol; 2012; 33(4):358-62. PubMed ID: 23091890 [TBL] [Abstract][Full Text] [Related]
25. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis. Kim TH; Lee HH; Chung SH; Park J; Lee A Arch Gynecol Obstet; 2015 Aug; 292(2):377-81. PubMed ID: 25666480 [TBL] [Abstract][Full Text] [Related]
26. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma. Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053 [TBL] [Abstract][Full Text] [Related]
27. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659 [TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
29. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. Jing Z; Nan KJ; Hu ML World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979 [TBL] [Abstract][Full Text] [Related]
30. Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation. Malicet C; Hoffmeister A; Moreno S; Closa D; Dagorn JC; Vasseur S; Iovanna JL Biochem Biophys Res Commun; 2006 Jan; 339(1):284-9. PubMed ID: 16300740 [TBL] [Abstract][Full Text] [Related]
31. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702 [TBL] [Abstract][Full Text] [Related]
32. Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis. Hsu JL; Chuang WJ; Su IJ; Gui WJ; Chang YY; Lee YP; Ai YL; Chuang DT; Huang W J Virol; 2013 Dec; 87(23):12675-84. PubMed ID: 24049181 [TBL] [Abstract][Full Text] [Related]
33. [Expression and their significance of Jab1 p27kip1 in laryngeal squamous cell carcinoma and Hep-2 cells]. Li F; Cao H; Wu Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 26(6):252-5, 259. PubMed ID: 22675932 [TBL] [Abstract][Full Text] [Related]
34. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606 [TBL] [Abstract][Full Text] [Related]
35. [Expression and relationship of p27(kip1) and its nuclear export factor Jab1 in lymphoma cell Jurkat]. Wang YC; Zhao YM; Shen AG; Lu JX; Zhang DM; He S; Cheng C Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):813-7. PubMed ID: 18476592 [TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669 [TBL] [Abstract][Full Text] [Related]
37. Jab1 regulates Schwann cell proliferation and axonal sorting through p27. Porrello E; Rivellini C; Dina G; Triolo D; Del Carro U; Ungaro D; Panattoni M; Feltri ML; Wrabetz L; Pardi R; Quattrini A; Previtali SC J Exp Med; 2014 Jan; 211(1):29-43. PubMed ID: 24344238 [TBL] [Abstract][Full Text] [Related]
38. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. Zhou Q; He Q; Liang LJ World J Gastroenterol; 2003 Nov; 9(11):2450-4. PubMed ID: 14606074 [TBL] [Abstract][Full Text] [Related]
39. A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27. Wu D; Wang Y; Yang G; Zhang S; Liu Y; Zhou S; Guo H; Liang S; Cui Y; Zhang B; Ma K; Zhang C; Liu Y; Sun L; Wang J; Liu L Oncogene; 2020 Sep; 39(38):6099-6112. PubMed ID: 32811980 [TBL] [Abstract][Full Text] [Related]
40. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]